Theravance Biopharma Stock (NASDAQ: TBPH) stock price, news, charts, stock research, profile.
Open | $8.07 |
Close | $7.94 |
Volume / Avg. | 220.70K / 395.01K |
Day Range | $7.93 - $8.08 |
52 Wk Range | 7.44 - 11.71 |
Market Cap | $388.44M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 21.68% |
Days to Cover | 24.18 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Theravance Biopharma (NASDAQ:TBPH) through any online brokerage.
Other companies in Theravance Biopharma’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Third Harmonic Bio (NASDAQ:THRD), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
Theravance Biopharma has a consensus price target of $13.00.
The stock price for Theravance Biopharma (NASDAQ: TBPH) is $7.94 last updated September 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Theravance Biopharma.
Theravance Biopharma’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Theravance Biopharma.
Theravance Biopharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.